Work

Abstract A013: 5-year mortality risk in multiple myeloma patients treated with car-t therapy: A comparison of pre-treatment with bendamustine vs. fludarabine and cyclophosphamide

Year: 2025

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2025-a013

Authors: Allen Seylani, Assal Sadighian, Sharanya Kumar, Yohannes Haile

Institution: University of California, Riverside

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407869042

Cites:

Cited by:

Related to: 10